What is Liraglutide (Victoza, Saxenda) and its mechanism of action
PlexusDx's licensed 503A pharmacy partners ensure all compounded medications meet pharmaceutical grade standards, and your provider monitors your safety throughout treatment
* Based on the average weight loss in three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced- calorie diet and increased physical activity
Weight, appetite levels, energy, gastrointestinal symptoms, and mood should all be monitored weekly
It reduces inflammation, improves mood, maintains muscle mass, and supports joint health
The goal was to learn, anticipate, and adjust for patient behaviors toward their treatment plans